Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
The only randomized clinical trial studying BPC-57 for pain control follows up patients for three weeks after a single-dose administration
Ligament research using rat medial collateral ligament transection models demonstrated that BPC-157 restored biomechanical properties including load tolerance, stiffness, and breaking force to near-normal levels while reducing joint instability
Thus, the RDA assumes an absorbed amount of 1.2 g per day (50% of 2.4 g) or 8.4 g per week
The appropriate syringe capacity is used for precise dosage delivery
People taking anticoagulants such as warfarin, apixaban, or rivaroxaban face compounded bleeding risk
Functional fertility endpoints in animal studies, such as mating success, pregnancies, litter size, and offspring viability after BPC-157, rather than just markers for tissue repair
